Consensus map of Closed form of PIC-Med-SWI/SNF

Tail of Mediator of PIC-Med-SWI/SNF

Consensus map of PIC-Med-SWI/SNF-Nucleosome

TFIIH of PIC-Med-SWI/SNF-Nucleosome

Composite map of open form of PIC-Med-SWI/SNF

Human mitochondrial ClpP in complex with OICR-18704 in a partially-engaged tetradecameric state (intermediate opening)

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 1, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 1, Focused map

Human mitochondrial ClpP V62A variant

Human mitochondrial ClpP in complex with OICR-18704 in a partially-engaged tetradecameric state (minimal opening)

Human mitochondrial ClpP in complex with OICR-18704 in the heptameric state

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 2, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 2, Focused map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 2, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 1, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 1, Focus map

Human mitochondrial ClpP in complex with OICR-18704 in a partially-engaged tetradecameric state (maximal opening)

Composite map of closed form of PIC-Med-SWI/SNF

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 2, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 3, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 3, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 8, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 3, Focused map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 3, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 9, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 9, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 7, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 7, Focus map

Nucleosome with an SSD at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 2

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 7

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 2

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 6, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 4, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 2, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 9

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 7, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 4, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 3, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 3, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 2, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 6, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1 and Talazoparib, Class 1

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 3

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 2

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 5

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 4

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 7

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 5

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 9, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 9, Focus

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 11, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 11, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 11

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 14, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 14, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 2, focus map

Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 1, consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1 and Olaparib, Class 1

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 14

Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 1, focus map

Focused map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in precatalytic conformation

Cryo-EM structure of CRBN bound to 2-[5-chloro-1-(4-piperidyl)indol-4-yl]-2,5-diazaspiro[3.4]octan-6-one in the open conformation

Disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in recognition conformation

Disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in precatalytic conformation

Cryo-EM structure of CARM1 in complex with ALIX

Cryo-EM structure of CRBN bound to 1-[1-(4-piperidyl)indol-4-yl]hexahydropyrimidine-2,4-dione in the open conformation

Raw map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in recognition conformation

Raw map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in precatalytic conformation

Cryo-EM structure of CRBN bound to 1-[1-(4-piperidyl)indol-4-yl]hexahydropyrimidine-2,4-dione in the closed conformation

Focused map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in recognition conformation

Cryo-EM structure of monomeric bovine heart cytochrome c oxidase in amphipol A8-35

Cryo-EM structure of homotypic CENP-A nucleosome isolated from human cells

Cryo-EM structure of HSP90-CDC37-PINK1 complex

Structure of Human Aspartate--tRNA ligase 3-154 with linker and FC : ATYR0101

Cryo-EM structure of heterotypic CENP-A/H3 nucleosome isolated from human cells

Rhoptry secretory apparatus of Toxoplasma gondii conformation 1

Rhoptry secretory apparatus of Toxoplasma gondii conformation 4

Mitochondrial ATP synthase monomer from Acanthamoeba castellanii

Rhoptry secretory apparatus of Toxoplasma gondii conformation 3

A composite map of the mitochondrial ATP synthase monomer from Acanthamoeba castellanii

CryoEM structure of respiratory complex III intermediate from Acanthamoeba castellanii

Mitochondrial Hsp60 from Acanthamoeba castellanii

Rhoptry secretory apparatus of Toxoplasma gondii conformation 2

Mitochondrial ATP synthase dimer from Acanthamoeba castellanii

F1 ATPase from Acanthamoeba castellanii

Mitochondrial MDH and OSCP in the peripheral stalk of ATP synthase in Acanthamoeba castellanii

Membrane region of Acanthamoeba castellanii mitochondrial ATP synthase dimer

CTE Type I

CTE Type I-like

Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 1, Myb domain focused)

Cdc45 and Sld3 Loading on MCM Double Hexamer

Cryo-EM structure of STITCHR (R2Tg and Cas9 nickase) bound to guide RNA, template RNA, and target DNA in the target-primed reverse transcription initiation state

Sld7 in Complex with DDK-bound MCM Double Hexamer

Sld3-CTD Docking on Mcm4-NTD-A and Mcm6-NTD-A

Two Cdc45-Sld3 molecules Bound on MCM Double Hexamer

Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 2)

Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 3)

Sld7 Tetramer in Complex with MCM Double Hexamer

A Cryo-EM Map with a Continuous Density of Sld3-CTD Binding on Mcm4-NTD-A and Mcm6-NTD-A

A Local Refined Structure for Sld7 in Complex with Dbf4-bound Mcm6

Cdc45, Sld3 and Sld7 in Complex with DDK-bound MCM Double Hexamer

A Cryo-EM map for Sld3-Sld7 on Cdc45 and DDK-bound MCM Double Hexamer with a Highly Dynamic Sld3N and Sld7N

Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 1)

Sld3-CTD Docking on Mcm4-NTD-A

CryoEM structure of DDB1-VprBP-Vpr-TET2(1129-1936) complex

CryoEM structure of DDB1-VprBP complex in "ARM-down" conformation

Immune complex comprising the HRSV preF trimer (SC-DM) and the monoclonal antibody Lor69 - Obtained by cryo-EM

De Novo RNA Pseudocycle, pC2-240-0

Plasmodium falciparum 17-PF subpellicular microtubule

Nucleosome scFv complex with a nick at SHL +5.3

Plasmodium falciparum 17-PF subpellicular microtubule associated with human hemoglobin (local refined map)

Plasmodium falciparum 17-PF subpellicular microtubule associated with human hemoglobin

Plasmodium falciparum 18-PF subpellicular microtubule

AND-1 map D

Replisome map A

Trans-1-azomorphine-3 bound mu opioid receptor Gi complex - Focused receptor map

Trans-2-azomorphine-3 bound mu opioid receptor Gi complex - Focused receptor map

Trans-2-azomorphine-3 bound mu opioid receptor Gi complex - Focused Gi map

Human replisome map 1

TIMELESS-TIPIN map C

cis-azomorphine-3 bound mu opioid receptor Gi complex - Focused Gi map

Cis-azomorphine-3 bound mu opioid receptor Gi complex - Focused receptor map

Replisome (map E)

MCM C-tier map B

Cis-azomorphine-3 bound mu opioid receptor Gi complex

Cis-azomorphine-3 bound mu opioid receptor Gi complex

Trans-1-azomorphine-3 bound mu opioid receptor Gi complex

Trans-1-azomorphine-3 bound mu opioid receptor Gi complex - Focused Gi map

Trans-2-azomorphine-3 bound mu opioid receptor Gi complex

Trans-1-azomorphine-3 bound mu opioid receptor Gi complex

Trans-2-azomorphine-3 bound mu opioid receptor Gi complex

cAMP-bound WT SthK in 4:1 DOPC:POPA nanodiscs

cAMP-bound SthK monomer from symmetry expanded particles - POPA class 1

cAMP-bound SthK monomer from symmetry expanded particles - POPA class 2

cAMP-bound SthK monomer from symmetry expanded particles - POPA class 3

cAMP-bound SthK monomer from symmetry expanded particles - POPA class 4

cAMP-bound SthK monomer from symmetry expanded particles - POPE class 2

cAMP-bound SthK monomer from symmetry expanded particles - POPA class 8

cAMP-bound SthK monomer from symmetry expanded particles - POPA class 6

cAMP-bound SthK monomer from symmetry expanded particles - POPA class 7

cAMP-bound SthK monomer from symmetry expanded particles - POPA class 5

cAMP-bound SthK monomer from symmetry expanded particles - POPE class 1

Cryo-EM structure of the flagellar filament in Vibrio parahaemolyticus VP288

Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), bound to diynyl arylamine (DA, aka RO-09-3143)

Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-7), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)

Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-4), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)

Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), state 2 (pre-translocation) after 5 min reaction

Cryo-EM structure of the LbCas12a-Lid2-crRNA-DNA complex

Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), state 3 (post-translocation) after 5 min reaction

Candida albicans Chitin synthase 1 (CaChs1) bound to UDP-GlcNAc and diynyl arylamine (DA, aka RO-09-3143)

Human CI-M6PR/IGF2R (cation-independent mannose-6-phosphate receptor) cryo-EM structure low pH conformation

Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-3), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)

Cryo-EM structure of P450 GpeC in complex with SGpeA1

Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1) in the apo state

Structure of photosystem I with plastoquinone-9 bound

Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-5), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)

Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-6), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)

Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-2), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)

Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), state 1 (post UDP hydrolysis) after 5 min reaction

Cryo-EM structure of the flagellar filament in Vibrio Cholerae

RIPK1 death domain filamentation drives TNF-induced apoptosis

Cryo-EM structure of bacteriophage A1002 overall capsid

Cryo-EM structure of human DHX9 in complex with ATX-968 and ADP.

Tetrameric structure of the TM6SF2 E167K variant

Cryo-EM map of the TM6SF2 dimer

Drosophila MSLHAT nucleosome complex H4K16ac postcatalytic H3K36me3 reader state overall refinement

MSL HAT nucleosome complex active H4K16Ac state Overall refinement

MSL HAT nucleosome complex active H4K16Ac state

Drosophila MSL HAT nucleosome complex H4K16ac postcatalytic H3K36me3 reader state focused refinement

Drosophila MSL HAT nucleosome complex H3K36me3 reader state

Tetrameric structure of TM6SF2

Drosophila MSL HAT nucleosome complex H4K16ac post-catalytic state

Cryo-EM map of mouse PADI6-UHRF1-UBE2D2 complex (state 2), featuring a tetrameric assembly of PADI6

Structure of mouse PADI6-UHRF1-UBE2D2 complex

Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the inverse agonist cmpd54-4, local

Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the inverse agonist cmpd54-4

Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the agonist dexamethasone phosphate (DEX-P),local

Structure of human PADI6

Cryo-EM structure of the MRGPRX4-miniGsq complex in the apo state

Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the agonist dexamethasone phosphate (DEX-P)

Negative stain EM map of E. coli 70S ribosome

Cryo-EM map of mouse PADI6 tetramer

Structure of mouse PADI6 dimer

Cryo-EM structure of the MRGPRX4-miniGsq complex in the apo state, local

Structure of mouse PADI6 oligomer

Drosophila MSL HAT nucleosome complex H4K16ac postcatalytic H3K36me3 reader state

Cryo-EM structure of human TMEM45A with a bound 2-Hydroxypalmitate

Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 1

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 7, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 10

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 9, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 10, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 8, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 10, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 5

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 1

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 9, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 5, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 6

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 1

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 7

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 5

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 7, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 8, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 9

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 3

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 2

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 4

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 2, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 5, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 2, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 4, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 3, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 3, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 4, Focus map

SARS-CoV-2 Omicron JD.1.1 spike trimer (S-6P) in complex with 3 R102-9 Fabs and 3 C092 Fabs, focused refinement of RBD and Fab region

SARS-CoV-2 Omicron JD.1.1 spike trimer (S-6P) in complex with 3 R102-9 Fabs and 3 C092 Fabs (3 RBD up)

Cryo-EM structure of hydrogenase-2 in complex with L1 (right)

Human condensin II bound to DNA

Cryo-EM structure of hydrogenase-2 in complex with L1 (left)

Human condensin II - M18BP1 complex

Human condensin II bound to ADP-BeF3 in autoinhibited conformation

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled mouse brain biopsy frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled mouse brain biopsy frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled mouse brain biopsy frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes

In-situ structure of the 80S yeast ribosome frozen in HPF Autogrid Planchettes

Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 5, Focus map

Cryo-EM structure of Human Apoferritin

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 5, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 6, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 6, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 2, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 8, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 2, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 4, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 4, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 7, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 7, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 6, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 5, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 6, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 1, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 3, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 4, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 3, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 4, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 6, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 6, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 1, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 5, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 1, Consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 1, Focus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 1, Focus map

TBP/TFIIE/DNA of PIC-Med-SWI/SNF-Nucleosome

Composite map of PIC-Med-SWI/SNF-Nucleosome

PolII/TFIIF of PIC-Med-SWI/SNF-Nucleosome

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 4

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 3

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 5

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 4

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 6

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 7

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 2

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 4

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 8

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 6

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 1

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 8

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 3

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 6

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1 and Olaparib, Class 6

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 3

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 9

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 10

Nucleosome with an SSb at SHL +5.3 in complex with the WGR domain of PARP2, Class 2, consensus map

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 8

Structural Insights into HIV-1 Vif-Mediated Ubiquitination and Degradation of APOBEC3H

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 13

Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 12

Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of PARP2, Class 2

Consensus map of Open form of PIC-Med-SWI/SNF